Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yulia, Pauker"'
Autor:
Adnan, Zaina, Ilan, Shimon, Ali, Abid, Eldad, Arad, Elzbieta, Baron, Elena, Golden, Michal, Gershinsky, Nariman, Saba Khazen, Mohammed, Abu Saleh, Noga, Roguin Maor, Orit, Bardicef, Yulia, Pauker, Sameer, Kassem
Publikováno v:
The Israel Medical Association journal : IMAJ. 24(7)
National registries for acromegaly and population-based data make an important contribution to disease understanding and management. Data concerning the epidemiology of acromegaly in Israel is scanty.To evaluate the epidemiology of acromegaly in diff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cca35b37be8117f58b8b05247d9695e7
https://pubmed.ncbi.nlm.nih.gov/35819213
https://pubmed.ncbi.nlm.nih.gov/35819213
Autor:
Yulia Pauker, Amit Akirov, Ilan Shimon, Michal Gershinsky, Nariman Saba Khazen, Alexander Gorshtein, Idit Dotan
Publikováno v:
Endocrine. 74(2)
Pasireotide long acting (LAR) can be effective in normalizing insulin-like growth factor (IGF)-1 level in acromegaly patients inadequately controlled by octreotide or lanreotide.Determine the long-term efficacy and safety of pasireotide, including ti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d851ca92b3f972576ca931745601478f
https://pubmed.ncbi.nlm.nih.gov/34081309
https://pubmed.ncbi.nlm.nih.gov/34081309
Autor:
Yulia Pauker, Ilan Shimon, Nariman Saba Khazen, Mark J Niven, Zaina Adnan, Carmela Shechner, Lior Baraf, Ali Abid, Alexander Gorshtein, Yona Greenman, Michal Gershinsky
Publikováno v:
Endocrine. 62(2)
Pasireotide, a multi-somatostatin receptor (SSTR)-ligand with high affinity for SSTR5 was recently approved for acromegaly treatment. A retrospective multicenter study investigating the efficacy and safety of long-acting (LAR) pasireotide treatment i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05ca95a258672a037d9aa6ac6c30fcf3
https://pubmed.ncbi.nlm.nih.gov/30051198
https://pubmed.ncbi.nlm.nih.gov/30051198
Autor:
Yulia Pauker, Carlos Benbassat, Orit Bardicef, Gloria Tsvetov, Odile Cohen-Ouaqnine, Liat Rot, Yoel Toledano, Zaina Adnan, Jacob Ilany, Sophia Orlovsky, Hadassah Guttmann, David Olchovsky, Ilan Shimon, Yona Greenman, Ofa Makhoul, Rosane Ness-Abramof, Achia Eliash, Mazal Sapir, Michal Gershinsky
Publikováno v:
Pituitary. 12:285-293
We investigated the effectiveness of lanreotide for the treatment of active acromegaly in a retrospectively multicenter case series including 53 patients (24 male, 29 female; mean age at diagnosis, 49.5 +/- 13.9 years) with acromegaly treated with la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca53ffcc4de758d603d75f02e0450208
https://doi.org/10.1007/s11102-009-0172-4
https://doi.org/10.1007/s11102-009-0172-4